Skip to main navigation Skip to search Skip to main content

A Randomized, Controlled Double-Blind Study Comparing the Efficacy & Safety of Orelvo (Voclosporin) (23.7 mg Twice Daily) with Placebo in Achieving Renal Response in Subjects with Active Lupus Nephritis

SUNY Downstate Health Sciences University

Project: Research

Project Details

StatusFinished
Effective start/end date07/12/17 → 07/11/20

Funding

  • Aurinia Pharmaceuticals Incorporated: $80,417.03